Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development - Image 1

£106.40

Wiley Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development

Name: Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development
Brand: Wiley
Price: 106.4 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£106 today · previous high £106 · all-time low £103

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 70 days • 54 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 70 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £104 (27 days, 50.0%)

Price range: £103 - £106

Price levels: 4 different prices over 54 days

Description

Molecules Engineered Against Oncogenic Proteins and Cancer A comprehensive review of the latest molecular advances in cancer treatment Featuring 91 total small molecule kinase/KRAS inhibitors, 80 of which are FDA-approved, Molecules Engineered Against Oncogenic Proteins and Cancer documents the recent scientific advances that have transformed one of medicine’s most challenging areas―cancer treatment. Most of these inhibitors specifically block oncogene-induced carcinogenic proteins with results that have dramatically advanced the treatment of cancer. In addition, the structural formulas of more than 100 kinase/KRAS inhibitors in clinical trials are presented. With a very well-known chemist as an author, Molecules Engineered Against Oncogenic Proteins and Cancer includes information on: Each molecule’s structure, function of the kinase target and relevance to cancer, the drug discovery process, and molecular details of drug action Mutated protein kinases as oncoproteins and targets for inhibition, along with the details of discovery for each antitumor antikinase agent History of oncoprotein inhibitors and their role in advancing the treatment and understanding of cancer The discovery process as a whole, effective strategies for innovation, ongoing challenges, and a glimpse of the future of the field Combining the most significant recent discoveries in a unique and useful way, Molecules Engineered Against Oncogenic Proteins and Cancer is an essential resource for researchers and students in bioscience, medicine, chemistry, and oncology as well as for those at industrial companies involved in therapeutic discovery.

Product Specifications

Brand: Wiley
Format: hardcover
ASIN: 1394207085
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 09 August 2023
Listed Since: 07 March 2023

Barcode

No barcode data available

Wiley Molecules Engineered Against Oncogenic Proteins and Cancer: Discovery, Design, and Development

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry and Pharmacology of Anticancer Drugs

Small Molecules for Cancer Treatment

Small Molecules in Oncology: 201 (Recent Results in Cancer Research)

Kinase Screening and Profiling: Methods and Protocols: 1360 (Methods in Molecular Biology, 1360)

Adverse Events and Oncotargeted Kinase Inhibitors

Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents: 3 (Enzyme Inhibitors Series)

Small Molecules in Oncology: 184 (Recent Results in Cancer Research, 184)

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 1991: 74 (Developments in Oncology, 74)

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 27–29, 1991: 74 (Developments in Oncology)

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Therapeutic Kinase Inhibitors: 355 (Current Topics in Microbiology and Immunology, 355)

Cancer Prevention: Dietary Factors and Pharmacology (Methods in Pharmacology and Toxicology)

Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)

Cancer Chemotherapy: Basic Science to the Clinic

Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development)

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Cancer Drug Design and Discovery

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Drug Resistance in Cancer Cells

Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (Cancer Drug Discovery and Development)

Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (Cancer Drug Discovery and Development)

Medicinal Chemistry of Anticancer Drugs